CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 187 filers reported holding CARA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $127,539 | -41.2% | 75,923 | -0.9% | 0.00% | – |
| Q2 2023 | $216,874 | +28436.1% | 76,634 | -50.5% | 0.00% | -100.0% |
| Q1 2023 | $760 | -51.7% | 154,817 | +5.8% | 0.00% | -50.0% |
| Q4 2022 | $1,572 | -99.9% | 146,385 | +0.7% | 0.00% | 0.0% |
| Q3 2022 | $1,360,000 | +9.1% | 145,323 | +6.5% | 0.00% | 0.0% |
| Q2 2022 | $1,246,000 | -21.1% | 136,427 | +5.0% | 0.00% | 0.0% |
| Q1 2022 | $1,579,000 | -0.2% | 129,977 | +0.1% | 0.00% | 0.0% |
| Q4 2021 | $1,582,000 | -21.8% | 129,889 | -0.8% | 0.00% | -33.3% |
| Q3 2021 | $2,023,000 | -4.7% | 130,914 | -12.0% | 0.00% | 0.0% |
| Q2 2021 | $2,123,000 | +82.5% | 148,808 | +177.8% | 0.00% | +50.0% |
| Q1 2021 | $1,163,000 | +34.8% | 53,569 | -6.1% | 0.00% | +100.0% |
| Q4 2020 | $863,000 | +23.6% | 57,036 | +3.9% | 0.00% | 0.0% |
| Q3 2020 | $698,000 | -35.4% | 54,876 | -13.1% | 0.00% | -50.0% |
| Q2 2020 | $1,080,000 | +39.0% | 63,143 | +7.4% | 0.00% | 0.0% |
| Q1 2020 | $777,000 | -21.2% | 58,788 | -3.9% | 0.00% | 0.0% |
| Q4 2019 | $986,000 | -4.1% | 61,175 | +8.8% | 0.00% | 0.0% |
| Q3 2019 | $1,028,000 | -6.3% | 56,239 | +10.3% | 0.00% | 0.0% |
| Q2 2019 | $1,097,000 | +20.2% | 51,006 | +9.6% | 0.00% | 0.0% |
| Q1 2019 | $913,000 | +59.3% | 46,540 | +5.6% | 0.00% | +100.0% |
| Q4 2018 | $573,000 | -14.9% | 44,072 | +56.9% | 0.00% | 0.0% |
| Q3 2018 | $673,000 | +31.7% | 28,088 | +5.4% | 0.00% | 0.0% |
| Q2 2018 | $511,000 | +63.3% | 26,660 | +5.4% | 0.00% | 0.0% |
| Q1 2018 | $313,000 | -2.2% | 25,306 | -3.1% | 0.00% | 0.0% |
| Q4 2017 | $320,000 | -24.5% | 26,111 | -15.8% | 0.00% | 0.0% |
| Q3 2017 | $424,000 | -9.8% | 31,002 | +1.5% | 0.00% | 0.0% |
| Q2 2017 | $470,000 | -2.3% | 30,537 | +16.7% | 0.00% | 0.0% |
| Q1 2017 | $481,000 | +103.8% | 26,162 | +3.1% | 0.00% | 0.0% |
| Q4 2016 | $236,000 | +15.7% | 25,382 | +4.0% | 0.00% | 0.0% |
| Q3 2016 | $204,000 | +28.3% | 24,407 | -26.1% | 0.00% | – |
| Q2 2016 | $159,000 | +34.7% | 33,028 | +73.5% | 0.00% | – |
| Q1 2016 | $118,000 | -62.5% | 19,041 | +2.0% | 0.00% | -100.0% |
| Q4 2015 | $315,000 | +35.8% | 18,666 | +15.1% | 0.00% | 0.0% |
| Q3 2015 | $232,000 | +34.9% | 16,216 | +14.4% | 0.00% | 0.0% |
| Q2 2015 | $172,000 | – | 14,180 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 3,193,057 | $51,440,000 | 39.10% |
| Chescapmanager LLC | 1,299,701 | $20,938,000 | 3.08% |
| Burrage Capital Management LLC | 284,170 | $4,578,000 | 3.07% |
| Cypress Capital Management LLC (WY) | 184,085 | $2,966,000 | 2.80% |
| DAFNA Capital Management LLC | 328,533 | $5,293,000 | 1.82% |
| Mesirow Financial Investment Management, Inc. | 21,169 | $341,000 | 1.44% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 471,575 | $7,597,000 | 1.14% |
| AdvisorShares Investments LLC | 79,821 | $1,286,000 | 0.80% |
| ETF MANAGERS GROUP, LLC | 750,680 | $12,093,000 | 0.42% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,300,000 | $37,053,000 | 0.25% |